GQLVX
Price
$12.33
Change
-$0.04 (-0.32%)
Updated
May 23 closing price
Net Assets
2.05M
VIVAX
Price
$65.93
Change
-$0.08 (-0.12%)
Updated
May 23 closing price
Net Assets
183.65B
Interact to see
Advertisement

GQLVX vs VIVAX

Header iconGQLVX vs VIVAX Comparison
Open Charts GQLVX vs VIVAXBanner chart's image
Glenmede Disciplined US Value Eq Ptf
Price$12.33
Change-$0.04 (-0.32%)
VolumeN/A
Net Assets2.05M
Vanguard Value Index I
Price$65.93
Change-$0.08 (-0.12%)
VolumeN/A
Net Assets183.65B
GQLVX vs VIVAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GQLVX vs. VIVAX commentary
May 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GQLVX is a StrongBuy and VIVAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVAX has more cash in the bank: 184B vs. GQLVX (2.05M). VIVAX pays higher dividends than GQLVX: VIVAX (2.22) vs GQLVX (1.73). GQLVX was incepted earlier than VIVAX: GQLVX (8 years) vs VIVAX (33 years). GQLVX (3.63) is less costly to investors than VIVAX (0.17). GQLVX is a more actively managed with annual turnover of: 72.00 vs. VIVAX (9.00). GQLVX has a lower initial minimum investment than VIVAX: GQLVX (0) vs VIVAX (3000). VIVAX annual gain was more profitable for investors over the last year : 4.71 vs. GQLVX (-5.60). VIVAX return over 5 years is better than : 75.18 vs. GQLVX (61.62).
GQLVXVIVAXGQLVX / VIVAX
Total Expense Ratio0.850.17500%
Annual Report Gross Expense Ratio3.630.172,135%
Fund Existence8 years33 years-
Gain YTD-0.4730.375-126%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets2.05M184B0%
Annual Yield % from dividends1.732.2278%
Returns for 1 year-5.604.71-119%
Returns for 3 years5.1121.9723%
Returns for 5 years61.6275.1882%
Returns for 10 yearsN/A97.35-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EQH52.130.29
+0.56%
Equitable Holdings
TGNA16.74N/A
N/A
TEGNA
FLGT20.28N/A
N/A
Fulgent Genetics
OFS8.29-0.15
-1.78%
OFS Capital Corp
ENSC2.17-0.06
-2.91%
Ensysce Biosciences